X
Roche and AbbVie’s Venclexta approved in CLL
https://pharmaphorum.com/news/roche-and-abbvies-venclexta-approved-in-cll/
Genentech
Affimed and Roche ink $5bn plus cancer immunotherapy deal
Deal is based on natural killer cell therapeutics
Genentech’s Rituxan approved for rare skin disease
The FDA has approved Genentech’s Rituxan (rituximab) for use in adults with moderate-to-severe pemphigus vulgaris (PV), making it the first treatment for the condition in more than 60 years.
Calling all Microbiologists – 5 great reasons to be in San Diego
Pharmaceutical Microbiology West Coast Conference 2018
Roche and AC Immune’s Alzheimer’s drug on right track
Data suggest high dose used in phase 3 trial is most effective
1 2